Synapsoft logo
AI Insights from Disclosures
Searching...
Icure Pharmaceutical Incorporation 175250
Searching...

Company Summary

Quarterly Performance Revenue Operating Margin

Market Sentiment

※ Click the graph to view AI analysis information for that month.
Revenue
Consolidated
Separate
Operating Income
Consolidated
Separate
Net Income
Consolidated
Separate

Financials

Excel

No financial data is available for this period.
~
Quarterly
Annual
No data is available for this period.

*Values beyond the fourth decimal place of the unit are displayed as '0/-0'

Financial Indicator Forecast

※ These forecasts are simple AI estimates based on historical data and may differ from actual results.

Company Overview

as of June 2026
Icure Pharmaceutical Incorporation, established in May 2000, engages in the development and manufacture of patch-type pharmaceuticals and the cosmetics OEM/ODM business, based on its source technology in drug delivery systems (DDS) and, within the DDS field, the fast-growing transdermal drug delivery system (TDDS). Its headquarters and research institute are located on Bongeunsa-ro, Gangnam-gu, Seoul, and it has a manufacturing facility in Bongdong-eup, Wanju-gun, Jeollabuk-do.
Representative Director Lee Yeongseok
Founded May 29, 2000
Corporation Type KOSDAQ
Industry Classification Manufacture of other chemical products
Corporate number 11011-1982720
Business number 114-81-99306
Phone Number 02-6959-6909
Fax Number 02-586-8580
Website icure.co.kr
Company Address 10 Bongeunsa-ro 104-gil, Gangnam-gu, Seoul
Products & Services

Financial Health

Executives

Employees

Shareholders

Industry revenue

Disclosures

Comments

0 / 255

AI Assistant